POS-247 ROXADUSTAT FOR THE TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS NOT ON DIALYSIS (NDD): A PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY

• J. BARRATT,
• B. Andric,
• A. Tataradze,
• M. Schömig,
• M. Reusch,
• U. Valluri,
• C. Mariat

Affiliations

J. BARRATT

University of Leicester, Nephrology, Leicester, United Kingdom

B. Andric

Health Center, Nephrology, Krusevac, Serbia

A. Tataradze

National Center of Urology, Urology, Tbilisi, Georgia

M. Schömig

Center for Dialysis and Nephrology, Nephrology, Heilbronn and Neckarsulm, Germany

M. Reusch

Astellas Pharma Europe B.V., TA Medical Specialties, Leiden, Netherlands

U. Valluri

Astellas Pharma Europe B.V., Biostatistics, Leiden, Netherlands

C. Mariat

CHU St Etienne, Service Nephrologie Dialyse Transplantation, St Etienne, France